Investors in Infinity Pharmaceuticals Inc (INFI - Get Report) saw new options become available this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INFI options chain for the new December 15th contracts and identified one put and one call contract of particular interest.The put contract at the $2.00 strike price has a current bid of 20 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $2.00, but will also collect the premium, putting the cost basis of the shares at $1.80 (before broker commissions). To an investor already interested in purchasing shares of INFI, that could represent an attractive alternative to paying $2.31/share today. Because the $2.00 strike represents an approximate 13% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 70%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 10.00% return on the cash commitment, or 71.51% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Infinity Pharmaceuticals Inc, and highlighting in green where the $2.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $3.00 strike price has a current bid of 20 cents. If an investor was to purchase shares of INFI stock at the current price level of $2.31/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $3.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 38.53% if the stock gets called away at the December 15th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if INFI shares really soar, which is why looking at the trailing twelve month trading history for Infinity Pharmaceuticals Inc, as well as studying the business fundamentals becomes important. Below is a chart showing INFI's trailing twelve month trading history, with the $3.00 strike highlighted in red: Considering the fact that the $3.00 strike represents an approximate 30% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 57%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 8.66% boost of extra return to the investor, or 61.91% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example is 145%, while the implied volatility in the call contract example is 148%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 253 trading day closing values as well as today's price of $2.31) to be 127%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Kraft Heinz Dips as Warren Buffett Says He Overpaid for Stake, Denies 3G Rift
Kraft Heinz KHC shares drifted lower Tuesday, extending a year-to-date decline of around 30%, after billionaire investor Warren Buffett said he 'overpaid' for the packaged food group when he purchased it along with 3G Capital in 2015, but pledged to support incoming CEO Miguel Patricio.
Facebook Libra Gets Mixed Reviews From Regulators as Cryptocurrencies Surge
Facebook's plans to launch a global digital currency next year, known as Libra, are getting mixed reviews from central bankers and regulators around the world, but the social media group's drive towards financial services could represent the next wave of tech-sector influence.
Micron, FedEx, Trump-Xi, Tesla and Amazon - 5 Things You Must Know
U.S. stock futures decline as investors take a defensive stance on risk ahead of this weekend's G-20 summit in Japan; Micron reports earnings Tuesday; FedEx, which also reports earnings, sues the U.S. government arguing new trade regulations put an 'impossible burden' on the company to monitor its shipments.
FedEx Files US Government Lawsuit Over 'Impossible Burden' of Package Liability
FedEx filed a lawsuit against the U.S. government late Monday arguing new trade regulations put an "impossible burden" on the world's biggest package delivery company to monitor the origins of shipments to and from the United States.